Landay A - Search Results

1

Inhibition of cytokine-driven human immunodeficiency virus type 1 replication by protease inhibitor.

Al-Harthi L, Roebuck KA, Kessler H, Landay A. Al-Harthi L, et al. Among authors: landay a. J Infect Dis. 1997 Nov;176(5):1175-9. doi: 10.1086/514110. J Infect Dis. 1997. PMID: 9359716

2

Immune reconstitution is comparable in antiretroviral-naive subjects after 1 year of successful therapy with a nucleoside reverse-transcriptase inhibitor- or protease inhibitor-containing antiretroviral regimen.

Landay AL, Spritzler J, Kessler H, Mildvan D, Pu M, Fox L, O'Neil D, Schock B, Kuritzkes D, Lederman MM; AIDS Clinical Trials Group 5014 Team. Landay AL, et al. J Infect Dis. 2003 Nov 15;188(10):1444-54. doi: 10.1086/379041. Epub 2003 Nov 13. J Infect Dis. 2003. PMID: 14624369 Clinical Trial.

3

A potent activator of HIV-1 replication is present in the genital tract of a subset of HIV-1-infected and uninfected women.

Spear GT, al-Harthi L, Sha B, Saarloos MN, Hayden M, Massad LS, Benson C, Roebuck KA, Glick NR, Landay A. Spear GT, et al. Among authors: landay a. AIDS. 1997 Sep;11(11):1319-26. doi: 10.1097/00002030-199711000-00005. AIDS. 1997. PMID: 9302440

4

Induction of HIV-1 replication by type 1-like cytokines, interleukin (IL)-12 and IL-15: effect on viral transcriptional activation, cellular proliferation, and endogenous cytokine production.

Al-Harthi L, Roebuck KA, Landay A. Al-Harthi L, et al. Among authors: landay a. J Clin Immunol. 1998 Mar;18(2):124-31. doi: 10.1023/a:1023246800353. J Clin Immunol. 1998. PMID: 9533656

5

A human immunodeficiency virus (HIV)-inducing factor from the female genital tract activates HIV-1 gene expression through the kappaB enhancer.

Al-Harthi L, Spear GT, Hashemi FB, Landay A, Sha BE, Roebuck KA. Al-Harthi L, et al. Among authors: landay a. J Infect Dis. 1998 Nov;178(5):1343-51. doi: 10.1086/314444. J Infect Dis. 1998. PMID: 9780254

6

Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy.

Smith KY, Valdez H, Landay A, Spritzler J, Kessler HA, Connick E, Kuritzkes D, Gross B, Francis I, McCune JM, Lederman MM. Smith KY, et al. Among authors: landay a. J Infect Dis. 2000 Jan;181(1):141-7. doi: 10.1086/315169. J Infect Dis. 2000. PMID: 10608760

7

Analysis of lymphocytes, monocytes, and neutrophils from human immunodeficiency virus (HIV)-infected persons for HIV DNA.

Spear GT, Ou CY, Kessler HA, Moore JL, Schochetman G, Landay AL. Spear GT, et al. Among authors: landay al. J Infect Dis. 1990 Dec;162(6):1239-44. doi: 10.1093/infdis/162.6.1239. J Infect Dis. 1990. PMID: 1977808

8

IL-10 cooperates with TNF-alpha to activate HIV-1 from latently and acutely infected cells of monocyte/macrophage lineage.

Finnegan A, Roebuck KA, Nakai BE, Gu DS, Rabbi MF, Song S, Landay AL. Finnegan A, et al. Among authors: landay al. J Immunol. 1996 Jan 15;156(2):841-51. J Immunol. 1996. PMID: 8543841

9

In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: effects of interleukin (IL)-12 and anti-IL-10.

Landay AL, Clerici M, Hashemi F, Kessler H, Berzofsky JA, Shearer GM. Landay AL, et al. J Infect Dis. 1996 May;173(5):1085-91. doi: 10.1093/infdis/173.5.1085. J Infect Dis. 1996. PMID: 8627058

10

Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus.

Chougnet C, Wynn TA, Clerici M, Landay AL, Kessler HA, Rusnak J, Melcher GP, Sher A, Shearer GM. Chougnet C, et al. Among authors: landay al. J Infect Dis. 1996 Jul;174(1):46-53. doi: 10.1093/infdis/174.1.46. J Infect Dis. 1996. PMID: 8656012

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

607 results

Search Page

Filters